Access the full text.
Sign up today, get DeepDyve free for 14 days.
Chenglong Liu, D. Ostrow, R. Detels, Z. Hu, L. Johnson, L. Kingsley, L. Jacobson (2006)
Impacts of HIV infection and HAART use on quality of lifeQuality of Life Research, 15
F. McGinn, J. Gahagan, Elaine Gibson (2005)
Back to work: vocational issues and strategies for Canadians living with HIV/AIDS.Work, 25 2
Rita Murri, Massimo Fantoni, C. Borgo, R. Visonà, A. Barracco, Agostino Zambelli, L. Testa, N. Orchi, V. Tozzi, Oliviero Bosco, Albert Wu (2003)
Determinants of health-related quality of life in HIV-infected patientsAIDS Care, 15
Blake Max, Blake Max, R. Sherer (2000)
Management of the adverse effects of antiretroviral therapy and medication adherence.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30 Suppl 2
L. Jacobson, Rui Li, Phair Jp, J. Margolick, C. Rinaldo, R. Detels, A. Muñoz (2002)
Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.American journal of epidemiology, 155 8
J. Ware, M. Kosinski (2004)
Interpreting SF&-36 summary health measures: A responseQuality of Life Research, 10
E. Schenker, L. Hultin, K. Bauer, J. Ferbas, J. Margolick, J. Giorgi (1993)
Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program.Cytometry, 14 3
R. Hays, W. Cunningham, C. Sherbourne, I. Wilson, A. Wu, P. Cleary, D. McCaffrey, J. Fleishman, S. Crystal, R. Collins, Ferd Eggan, M. Shapiro, S. Bozzette (2000)
Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study.The American journal of medicine, 108 9
(1993)
Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
Xiuhong Li, J. Margolick, C. Conover, Sheila Badri, S. Riddler, M. Witt, L. Jacobson (2005)
Interruption and Discontinuation of Highly Active Antiretroviral Therapy in the Multicenter AIDS Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 38
Bastardo Ym, C. Kimberlin (2000)
Relationship between quality of life, social support and disease-related factors in HIV-infected persons in VenezuelaAIDS Care, 12
Seth Hetherington, S. McGuirk, Gwendolyn Powell, A. Cutrell, O. Naderer, Bill Spreen, S. Lafon, G. Pearce, H. Steel (2001)
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.Clinical therapeutics, 23 10
J. Giorgi, Hui Cheng, J. Margolick, K. Bauer, J. Ferbas, M. Waxdal, I. Schmid, L. Hultin, A. Jackson, Lawrence Park, Jeremy Taylor (1990)
Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group.Clinical immunology and immunopathology, 55 2
Andrew Blalock, J. McDaniel, E. Farber (2002)
Effect of employment on quality of life and psychological functioning in patients with HIV/AIDS.Psychosomatics, 43 5
J. Ware (2003)
SF-36 health survey: Manual and interpretation guide
K. Anastos, Yolanda Barrn, M. Cohen, R. Greenblatt, H. Minkoff, Alexandra Levine, Mary Young, S. Gange (2004)
The Prognostic Importance of Changes in CD4+ Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral TherapyAnnals of Internal Medicine, 140
Y. Mouton, S. Alfandari, M. Valette, François Cartier, P. Dellamonica, G. Humbert, J. Lang, P. Massip, D. Mechali, P. Leclercq, J. Modai, H. Portier (1997)
Impact of protease inhibitors on AIDS‐defining events and hospitalizations in 10 French AIDS reference centresAIDS, 11
C. Kleeberger, J. Phair, S. Strathdee, R. Detels, L. Kingsley, L. Jacobson (2001)
Determinants of Heterogeneous Adherence to HIV‐Antiretroviral Therapies in the Multicenter AIDS Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 26
(2005)
Family Foundation Panel on Clinical Practices for the Treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
H. Krentz, M. Gill (2003)
The impact on health-related quality of life of treatment interruptions in HIV-1-infected patients.AIDS, 17 4
S. Hammer, Kathleen Squires, M. Hughes, Michael Hughes, J. Grimes, L. Demeter, J. Currier, J. Eron, J. Feinberg, H. Balfour, L. Deyton, J. Chodakewitz, M. Fischl, J. Phair, W. Spreen, L. Pedneault, B. Nguyen, Jon Cook (1997)
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.The New England journal of medicine, 337 11
L. Eller (2001)
Quality of Life in Persons Living With HIVClinical Nursing Research, 10
R. Detels, A. Muñoz, G. McFarlane, L. Kingsley, J. Margolick, J. Giorgi, L. Schrager, J. Phair (1998)
Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.JAMA, 280 17
A. Wu (2000)
Quality of life assessment comes of age in the era of highly active antiretroviral therapy.AIDS, 14 10
H. Kessler, Judy Johnson, S. Follansbee, M. Sension, D. Mildvan, Gladys Sepúlveda, Nicholaos Bellos, S. Hetherington (2002)
Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 4
R. Quercia, E. Garnier, V. Ferré, P. Morineau, B. Bonnet, C. Soulard, F. Raffi (2005)
Salvage Therapy with Ritonavir-Boosted Amprenavir/Fosamprenavir: Virological and Immunological Response in Two Years Follow-upHIV Clinical Trials, 6
I. Wilson, P. Cleary (1996)
Clinical predictors of functioning in persons with acquired immunodeficiency syndrome.Medical care, 34 6
P. Tarwater, J. Gallant, J. Mellors, M. Gore, J. Phair, R. Detels, J. Margolick, A. Muñoz (2004)
Prognostic value of plasma HIV RNA among highly active antiretroviral therapy usersAIDS, 18
A. Burgess, Mark Dayer, Jose Catalan, David Hawkins, B. Gazzard (1993)
The reliability and validity of two HIV-specific health-related Quality-of-Life measures: a preliminary analysis.AIDS, 7 7
L. Radloff (1977)
The CES-D ScaleApplied Psychological Measurement, 1
C. Worthington, H. Krentz (2005)
Socio-economic factors and health-related quality of life in adults living with HIVInternational Journal of STD & AIDS, 16
R. Kaslow, D. Ostrow, R. Detels, J. Phair, B. Polk, C. Rinaldo (1987)
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.American journal of epidemiology, 126 2
I. Wilson, P. Cleary (1995)
Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.JAMA, 273 1
E. Bing, R. Hays, L. Jacobson, Baibai Chen, S. Gange, N. Kass, J. Chmiel, S. Zucconi (2004)
Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort StudyQuality of Life Research, 9
E. Clingerman (2004)
Physical Activity, Social Support, and Health-Related Quality of Life Among Persons With HIV DiseaseJournal of Community Health Nursing, 21
Robert Johnson, F. Wolinsky (1993)
The structure of health status among older adults: disease, disability, functional limitation, and perceived health.Journal of health and social behavior, 34 2
S. Gange, L. Jacobson, A. Muñoz (1996)
Parametric models to assess tracking of categorical high-risk sexual behaviour for HIV infection.Statistics in medicine, 15 21-22
Downloaded from http://journals.lww.com/jaids by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/12/2020 EPIDEMIOLOGY AND SOCIAL SCIENCE Predictors for Lower Quality of Life in the HAART Era Among HIV-Infected Men Chenglong Liu, MD, PhD,*Þ Lisette Johnson, MS,* David Ostrow, MD, PhD,þ Anthony Silvestre, PhD,§ Barbara Visscher, MD, DrPH,|| and Lisa P. Jacobson, ScD* visits, depression, amprenavir use, antiretroviral drug interruption, Background: In the era of highly active antiretroviral therapy recreational drug use, and less social support were significantly (HAART), maximizing health-related quality of life (QOL) has associated with lower mental health summary score. become a high priority of long-term management of HIV-infected Discussion: Many predictors of lower QOL are alterable risk factors individuals. Modifiable determinants of lower QOL should be that can be effectively targeted for interventions to maximize patients’ identified for interventions specifically targeted to the HAART- QOL. With appropriate treatment and management of HIV disease using individuals to improve their QOL. and depression, clinicians can help improve the QOL of their patients. Objective: To identify the predictors for lower QOL among Through modification of individual risk behaviors, HIV-infected HAART-using study participants in the Multicenter AIDS Cohort individuals can enhance their own QOL with support from clinicians Study, a longitudinal study of HIV infection
JAIDS Journal of Acquired Immune Deficiency Syndromes – Wolters Kluwer Health
Published: Aug 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.